Siga Technologies (SIGA) Other financing activities (2017 - 2018)
Siga Technologies' (SIGA) quarterly Other financing activities came in at $9200.0 in Q4 2018, down 85.16% YoY from $62001.0 in Q4 2017, and down 96.36% on a QoQ basis from $252679.0 in Q3 2018.
Siga Technologies (SIGA) Other financing activities (2017 - 2018) Analysis & Trends
Siga Technologies (SIGA) has 2 years of Other financing activities data on file, last reported at $9200.0 in Q4 2018.
- Quarterly Other financing activities fell 85.16% year-over-year to $9200.0 in Q4 2018, while the trailing twelve-month figure through Dec 2019 was $323880.0 (changed 0.0% YoY) and the FY2018 annual result came in at $261879.0, up 192.61% from the prior year.
- Other financing activities slipped to $9200.0 in Q4 2018, from $252679.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $252679.0 in Q3 2018 to a low of $9200.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Siga Technologies | 212.31 Mn | 57.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9,200.00 |
| Dec 31, 2018 | 9,200.00 |
| Sep 30, 2018 | 252,679.00 |
| Sep 30, 2018 | 252,679.00 |
| Dec 31, 2017 | 62,001.00 |
| Dec 31, 2017 | 62,001.00 |